Turning Point Brands Q1 sales rise 16.8%, profit falls 19%; raises Modern Oral outlook
Turning Point Brands reported first-quarter 2026 net sales up 16.8% to $124.3 million, but net income attributable to the company fell 19.0% to $11.7 million and diluted EPS dropped to $0.60 from $0.79. The company raised its full-year 2026 Modern Oral sales guidance and introduced full-year Adjusted EBITDA guidance of $70 million to $90 million, so shareholders get higher sales expectations alongside lower first-quarter profit.
Key points
- Q1 2026 net sales rose 16.8% to $124.3 million; Stoker's rose 48.1% while Zig-Zag fell 22.4%
- Net income attributable to the company was $11.7 million, down 19.0%; Adjusted EBITDA fell 6.5% to $25.9 million
- FY2026 Modern Oral net sales guidance raised to $210 million-$225 million from $180 million-$190 million
- Operating cash flow was negative $22.3 million for the quarter, and cash ended March 31, 2026 at $192.4 million
The filing
Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 07, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.